Related Experiment Videos
Anticoagulation in neurosurgical patients
1Department of Neurosurgery, University of Maryland School of Medicine, Baltimore 21201, USA.
Neurosurgery
|October 9, 1999
Summary
Managing anticoagulation (AC) in neurosurgery patients requires balancing bleeding risks and preventing clots. Guidelines are proposed to safely restart AC after intracranial hemorrhage or surgery, considering individual thromboembolic risk.
Area of Science:
- Neurosurgery
- Cardiology
- Vascular Surgery
Background:
- Limited guidelines exist for managing anticoagulation (AC) in neurosurgical patients.
- Decisions on initiating or discontinuing AC post-surgery or hemorrhage are complex.
- Balancing AC's benefits against bleeding risks is crucial.
Purpose of the Study:
- To formulate guidelines for AC management in neurosurgical patients.
- To base recommendations on patient AC needs and complication risks.
- To address the lack of clear neurosurgical AC protocols.
Main Methods:
- Systematic review of neurosurgical and general surgical literature on AC management.
- Survey of general medical and surgical literature for thromboembolic risks.
- Analysis of factors influencing postoperative bleeding and thromboembolic complications.
Main Results:
- Inadequate preoperative coagulation correction, early (24-48h) AC reintroduction, and supratherapeutic AC increase bleeding risk.
- Thromboembolic complication risk varies significantly based on the underlying condition requiring AC.
- Preoperative optimization and strict AC regulation are key to preventing complications.
Conclusions:
- Preoperative coagulation correction and avoiding supratherapeutic AC are essential.
- Reintroducing AC after intracranial events can be risk-stratified (high, moderate, low thromboembolic risk).
- Proposed therapeutic options for AC use in neurosurgical patients undergoing intracranial procedures.